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Introduction
It has been said that, a primary determinant of treatment success is 
adherence to therapy [1]. A lack in adherence to psychiatric therapies 
has been shown to result in an increase of relapses, re-hospitalizations, 
evolutions towards chronicity, various kinds of psychic and somatic 
complications, and an increase in health care costs. According to 
the World Health Organization, the degree of low adherence toward 
medication, in all illnesses in general, is so great and the consequences 
are of such concern, that worldwide people would benefit more from 
the efforts to improve adherence than from the development of new 
medical treatments [2]. In Psychiatry, this problem seems to be more 
relevant than in the rest of Medicine. Counseling about medication 
adherence for the three major diseases states: in Schizophrenia, Mood 
Disorders, and Personality Disorders, thatis important to educate 
patients and their families about the consequences of not appropriately 
treating these conditions, which can result in psychotic attacks, 
increases in aggressiveness, suicides, potentially permanent losses of 
social skills and devastating alterations to their quality of life [3].
Compliance and Adherence
Compliance once widely used and sometimes confused with 
adherence, refers to a patient’s obedience to therapy under the authority 
of the physician, rather than to a collaborative approach. It is evident 
that we must abandon this term in Psychiatry, whereas the relationship 
between caregiver and patient is the main reason through which we 
can “take care”. That is also the reason why we can speak of compliance 
in Psychiatry only when we refer to specific treatments in case of 
emergency, urgency, lack of consciousness or imminent danger for the 
patient himself or someone else.
Adherence is the degree to which the patient’s behavior is in 
agreement with the health caregiver’s recommendations. That is a 
collaborative approach between the patient and the psychiatrist in 
which the therapeutic relation makes a strong frame where the patient’s 
values, lifestyle, and beliefs are still his own property, but he nevertheless 
can share with his “doctor” advice, opinions and prescriptions that 
concern the value of his own health.
Another term that relates to adherence is persistence, which is 
the patient’s ability to continue taking the medication for the duration 
of treatment. Discussing the intended course of the therapy with the 
patient has been shown to help the patient follow constantly his or her 
medication regimen [4].
Factors that Influence Adherence
The most consistently reported factors, which have had an impact 
on adherence in Psychiatry, are seriousness of illness, acute psychotic 
episodes, chronicity, relevance of side effects, low literacy, poor social 
support, elevated family grade of EE, and homelessness. Patient’s 
beliefs about diagnosis and medication effects have also shown to 
affect the adherence rate. This is particularly true with psychotropic 
medications that are still objects of stigma and wide prejudices among 
general population [2]. If an anti-diabetic drug can be seen only as 
a medication, a neuroleptic drug or even a simply hypnotic one, are 
generally felt like “real psychotropic drugs” that can modify the brain or 
the functioning of the mind. These sensations can cause a wide variety 
of reactions among patients, families, health officers, and so on, that go 
from scare, to curiosity, overtaking, and open refusal.
The Role of a Third Significant Person 
 Psychiatrists, relatives, nurses, social helpers and even pharmacists 
can promote an increase in communications between health caregivers 
and patients. This at least will improve adherence and outcomes. 
Questions like, “What is my main problem?What do I need to do?Why 
is itimportant for me to do this?” All those who support patients should 
be able to instruct them to ask these three questions, state them to 
patients and answer them in case patients do not ask. When answering 
these questions, particularly with less-symptomatic patients, it is 
helpful to remind patients of the consequences of failing to take their 
medication, such as a devastating in their social or familiar relationship, 
in their abilities or individual suffering [5]. A full treatment adherence 
may include being interested in one’s health and understanding the 
diagnosis, comprehending the impact or potential impact of the 
diagnosis, believing that what has been prescribed will help to know 
precisely how to take the medication and for how long. Other requisites 
may be determining how to fit the medication into one’s daily routine, 
valuing the results of treatment more than the cost of therapy, believing 
that one can fulfill the treatment plan, feeling that the physician has true 
concern for the patient as a person, as opposed to the simple treating of 
the disease [6]. If a complete adherence to therapy is difficult to obtain 
in current medical practice, it is much more complicated in psychiatric 
practice. 
Adherence to Chronic Diseases in Psychiatry: 
Sisyphus between Pharmacological Treatments and 
Psychotherapies
Poor adherence from illness
Sometimes the Psychiatric Disorder itself can lead the patient 
to misunderstand the meaning of his symptoms or misevaluate the 
secondary effects. For example: the presence of paranoid ideation may 
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lead the patient to the idea to be poisoned from the caregiver himself. 
The disappearance of symptoms is one of the main goals of medical 
treatment, but for a chronic schizophrenic patient that has been living 
for many years in a balanced relationship with “aliens”crowding his 
mind, their unexpected escape, secondaryto a strong antipsychotic 
therapy, can scare him, until the extreme consequences of a grief. 
A depressed patient can lie to everyone about his adherence to an 
antidepressant therapy with the only purpose to refuse the recovery, or 
in some cases to accumulate drugs to attempt suicide [7]. Many patients 
try to manipulate therapists, nurses, relatives just because they strongly 
believe that they are not sick, or simply, they are not mentally disturbed, 
or do not want people to look at them as “crazy”. The adherence with 
psychiatric patients involves the ability of the psychiatrist and his helpers 
to create a close therapeutic alliance where the patient feels the strong 
sensation he is protected against everyone, even against his own rage. 
The “frame” of the therapeutic relationship has to be so well- 
constructed as to resist to an extremely hard pressure, both from 
environmental factors and internal forces. Chronic Psychiatric 
Disorders treatment’s adherence requires a strong integration between 
psychological intervention and drugs administration [8].
When the refuse come from a lack of integration in the 
treatment
The story of the integration between biological and psychological 
therapies in the treatment of Mental Disorders runs right through 
the history of Psychiatry and is well- represented with the myth of 
Sisyphus, where the interminable and frustrating psychiatric work 
is greatly due to the opposition brain/mind [9]. Within the specific 
context of Mood Disorders, antithetical positions are encountered 
which range from discouraging every association of psychotherapy 
with pharmacological treatment, judged to be useless or damaging, 
to the more recent re-assessments of psychological treatments, at 
least in cases of greater management complexity, including chronicity 
and/or poor adherence. In addition to the primary drug-phobia, 
which derives directly from primary psychiatric pathology or from 
a comorbidity disease, sometimes drug-phobia appears for the first 
time, or it increases, during a long-term treatment. Once all cognitive, 
rational and pharmacological tools have been unsuccessfully used, we 
should investigate more thoroughly within the therapeutic relationship. 
Consequently, what is possible to recognize, it is not limited to chronic 
therapy of psychiatric patients, but can be applied to many other 
medical treatments. The refusal of the drug sometimes arises from a 
mechanism of distrust and devaluation of the therapist, if not at times 
of ambivalence or aggression against him. Other times drug phobia 
may represent a focused mode and partial resistance to changes and 
the care that affect the drug, more like a metaphorical object, that as 
real and concrete danger. Sometimes the resistance to “healing” derives 
from secondary benefits relating to family relations, work privileges, 
love affairs, economic questions, being, however, the mechanisms that 
generate them completely unknown to the patient. In a case where the 
physician does not recognize a pseudo-resistance to drugs, he may 
increase his control on drug intakes and his interventions of reproach 
and coercion even indirectly on family members. On the other hand, if 
a pseudo-resistance to drugs appears to be a concrete resistance to care, 
the physician will be lead to a constant change in strategy thus devaluing 
his role [10]. Other times the pseudo-drug resistance ends to mask, the 
desire to continue the therapeutic relationship and this happens both 
when it may be easily recognized as an eroticized transfer, and when the 
patient has strong bonds of therapist addiction. In even more complex 
cases that are fortunately rare, during the treatment of chronic diseases, 
a pseudo-drug resistance may appear, generated by deep feelings of 
guilt. The pseudo-drug resistance in a sort of moral masochism seems 
to grow when the therapist aims at reaching a fast healing or when the 
patient perceives as excessive his therapist’s narcissistic expectations. 
One example: bipolar disorders. A pathology where 
psychotherapy might be superfluous
Bipolar Disturbances, where the introduction of equilibrators 
seems to have swept away every need for psychotherapeutic treatment, 
and where we continue to see unexplainable relapses may represent a 
very particular situation [4]. Many Chronic Bipolar patients assume 
their stabilizer therapy, just for one week before its plasma dosing. 
We have to call it drug-resistance, non-responders, or simply do we 
have to look inside the medical-patient relationship? A poor and not 
psychotherapeutic oriented relation, where in some cases the physician 
as the only role of a drug-dispenser. The bio-technological supremacy 
of aseptic drugs such as the stabilizers is, in fact, stymied by a series of 
situations in which the emotional-affective instability, which remains 
after pharmacological treatment, is no longer biologically modifiable. 
The refusal of a new therapy cannot be read, at this point, onlyas an 
adherence’s reduction after years of treatment, but even as positive 
signal that the unconscious of the patient gives his therapist in order 
to try to understand and elaborate this instability only by psychological 
instruments [4]. Probably it will occur that in the chronic treatment of 
Bipolar Disorder, as in many other Psychiatric Diseases, a new drug 
therapy will have to be prescribed in the future. The “pause” the patient 
sometimes requires between two different biological interventions, can 
be managed better with psychological tools than with pharmaceutical 
dispositions, and, once again, the ineluctability of the renewal of 
psychiatric work recalls the fatigues of Sisyphus [11].
Another Obstacle to Adherence: the Stigma
Environmental factors include still at the first place the “stigma” 
that mental illnesses have and the prejudices around psychotropic 
medications. Those factors influence the general attitude of the patient’s 
entourage to refuse, reduce, or to increase the prescribed therapies 
without any consultation from the caregiver or in the worst cases 
with his collusion [12]. Particularly symbolic meanings attributed to 
psychotropic drugs, heavily condition the feelings towards drugs. 
Moreover, the characteristics of many side effects and the appearance 
of frequent iatrogenic pathologies easily cause the worsening of 
the subjective suffering and the relational chances of the patient, 
thus leading to an accentuation of refusal, isolation, relegation and 
stigmatization of the patient from others. The management of all 
psychiatric treatments needs therefore a well-trained caregiver, who 
can work in a team, where nurses, social helpers and relatives play well-
definite roles, whose purpose is the maintenance of the therapeutic 
relation inside the therapeutic frame. A group of people working 
together, is not a team, but fighting together against the “stigma”, may 
be the very first step to move towards the main objective, and finally, 
taking care of a person whose sufferings are not necessarily limited to 
somatic pain or glandular dysfunction, involves the essence itself of the 
personality and mind [13]. 
How to Overcome Adherence Challenges
Whenever it is possible, a psychiatrist, as any other physician, must 
create a shame-free environment. He must promote open dialogue, 
using a plain language instead of a medical terminology, providing 
written communication when necessary. New interactive technologies 
may be useful in some cases, even simply picture or video instructions.
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Involving family members, social helpers, home nurses as much as 
possible are goals very useful in long-term treatments. Simply things: 
like having the patient repeat the instructions, following up by telephone, 
to confirm the patient’s understanding, play an incredible strong role in 
the maintenance of therapy [14]. In any case psychiatrists need to know 
also all the right strategies to overcome low health literacy. These entire 
rational and sequential steps are unfortunately non-sufficient in many 
cases [15].
The therapeutic relationship. “Handle with Care”
Many other different factors can affect adherence to psychiatric 
cure. One first step is to prepare psychiatrists that can manage every 
treatment with a “psychotherapeutic attitude”. They have to be able to 
understand that when they prescribe a therapy, they prescribe a little 
of themselves, and in all case the relationship with the patient is a 
metaphoric triangle, where the drug, the patient or even the therapist, 
may be excluded. A well-structured psychological training, may be 
useful, but unfortunately is not sufficient, if the physician has a not clear 
difference between compliance and adherence. 
The knowledge of pharmacodynamic and pharmacokinetic of 
psychotropic drugs is essential
Psychiatrists prescribe drugs that undergo the general rules 
of pharmacology. Rules that are too often forgotten: for example, 
a simplification of the dosing regimen can affect adherence in a 
significant manner. Sometimes repeated assumptions are not justified 
by pharmacokinetic properties of drugs, but by the need to treat 
relatives, environment or psychiatrist’s anxiety.
In these cases the patient itself, some relatives, or even a nurse, 
may reduce the number of assumptions with an augmentation of single 
dose, without any medical approbation.
New antipsychotics, with their simplified regimen of administration, 
offer more advantages even in terms of adherence [16].
The role of long-acting drugs – It is ever a good solution?
The use of long-acting therapy is in many cases a great solution, 
when all strategies were played but the patient still has a refuse of the 
biological therapy, or a poor or uncertain adherence. No doubts about 
the improvement on the course, reduction of relapses, prognosis and 
efficacy that these drugs have dramatically had on Mental Illness [17-19].
Here we have just to underline, that, if, at a certain point of a 
treatment, we can obtain a better adherence with oral drug, we might 
change the strategy of therapy. Long-acting drugs sometimes are felt 
as a coactive and distancing therapy [1,20,21]. Moreover, the clinical 
management of variations, side effects or interactions of depot drugs it 
is not always simple.
Conclusion
Poor adherence to psychiatric medication is multifactorial, 
including mental illness itself with his capacities to create distortions 
in communications. A wrong adherence affects the patient’s confidence 
and his understanding of the diagnosis and how the medication 
will help his prognosis. Many important questions to answer for the 
patient concernmanaging the most disturbing symptoms. What does 
the patient need to do? Why is it important for the patient to do this? 
After these questions have been answered, the patient’s confidence on 
the treatment effectiveness will increase [3]. Only a stable therapeutic 
frame, where the triadic relationship among psychiatrist, patient and 
drug can be read with all its meanings of refusal, escape, anger, love, 
manipulation, or even sexual perversion, can prevent lack of adherence. 
During chronic treatment, especially the one, which last years and years 
with subtle, but constant increasing in social skills or in the reduction 
of psychotic symptoms, psychiatrist may fall into a trap: the “mirage” of 
a complete recovery. Finally a “true relationship” between psychiatrist 
and his patient where drug can be expelled. A situation where the 
dream of recovering from a chronic serious mental illness is sustained 
by a chronic narcissistic omnipotence of the therapist.
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